Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- GST101Phase 21 trial
Genuine Seed Therapeutics (Zhuhai) Co., Ltd. · RAS-mutant Advanced Solid Tumors
- GT-02287GT-02287 400, GT-02287 800Phase 21 trial
Gain Therapeutics, Inc. · Parkinson Disease
- GT101Phase 21 trial
Grit Biotechnology · Recurrent or Metastatic Cervical Cancer
- GT719Phase 21 trial
Grit Biotechnology · Hematological Malignancy (Leukemia- Lymphoma)
- GTAEXS617REC-617Phase 21 trial
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Pancreatic Adenocarcinoma, Non-small Cell Lung Cancer (NSCLC)
- GTX-102Phase 21 trial
Ultragenyx Pharmaceutical Inc · Angelman Syndrome
- GVB-2001Phase 21 trial
IVIEW Therapeutics Inc. · Primary Open-Angle Glaucoma (POAG)
- GVV858Phase 21 trial
Novartis · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, Metastatic Castration-resistant Prostate Cancer
- GXV813Phase 21 trial
Novartis · Schizophrenia
- GZR101-80Phase 21 trial
Gan & Lee Pharmaceuticals. · Type 2 Diabetes (T2DM)
- GZR102Phase 21 trial
Gan & Lee Pharmaceuticals. · Type 2 Diabetes Mellitus (T2DM)
- H001Phase 21 trial
Livzon Pharmaceutical Group Inc. · Circulatory Disease
- HA131Phase 21 trial
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC)
- HB-201HB-202 alternating using CD8 PET Tracer, Zr-Df-IAB22M2CPhase 21 trial
Hookipa Biotech GmbH · HPV-Related Squamous Cell Carcinoma
- HB-202Phase 21 trial
Hookipa Biotech GmbH · HPV-Related Squamous Cell Carcinoma
- HB0017Phase 21 trial
Huabo Biopharm Co., Ltd. · Psoriasis (PsO)
- HB0034Phase 21 trial
Shanghai Huaota Biopharmaceutical Co., Ltd. · Generalized Pustular Psoriasis (GPP)
- HB0036Phase 21 trial
Shanghai Huaota Biopharmaceutical Co., Ltd. · Advanced Solid Tumor, NSCLC
- HB0052Phase 21 trial
Shanghai Huaota Biopharmaceutical Co., Ltd. · Solid Tumors
- HBI-3000sulcardine sulfatePhase 21 trial
HUYABIO International, LLC. · Atrial Fibrillation
- HC010Phase 21 trial
HC Biopharma Inc. · NSCLC
- HCB101Phase 21 trial
FBD Biologics Limited · Solid Cancer
- HCW9218Phase 21 trial
ImmunityBio, Inc. · Advanced Pancreatic Carcinoma
- HD-6277Phase 21 trial
Hyundai Pharm · Type 2 Diabetes Mellitus (T2DM)
- HDM2005Phase 21 trial
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · Diffuse Large B Cell Lymphoma (DLBCL)
- HDP-101Phase 21 trial
Heidelberg Pharma AG · Multiple Myeloma, Plasma Cell Disorder
- HEC53856Phase 21 trial
Sunshine Lake Pharma Co., Ltd. · Chemotherapy-induced Anemia, Non-Myeloid Malignancy
- HEC88473Phase 21 trial
Dongguan HEC Biopharmaceutical R&D Co., Ltd. · Type 2 Diabetes
- HeXell-2020Phase 21 trial
Hexun Biosciences Co., LTD. · Coronary Artery Disease
- HG146Phase 21 trial
HitGen Inc. · Adenoid Cystic Carcinoma, Head and Neck Cancer
- HGT-1110Recombinant human arylsulfatase APhase 21 trial
Takeda · Metachromatic Leukodystrophy (MLD)
- HH-006Phase 21 trial
Huahui Health · Chronic Hepatitis B Virus Infection
- HK-660SPhase 21 trial
CuromeBiosciences · Primary Sclerosing Cholangitis (PSC)
- HL-085Phase 21 trial
Shanghai Kechow Pharma, Inc. · Neurofibromatosis 1, Plexiform Neurofibromas
- HL-300Phase 21 trial
Hangzhou Highlightll Pharmaceutical Co., Ltd · Atopic Dermatitis
- HLX-1502Phase 21 trial
Healx Limited · Neurofibromatosis Type 1
- HLX01Phase 21 trial
Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)
- HLX26Phase 21 trial
Shanghai Henlius Biotech · NSCLC Stage IV
- HLX53Phase 21 trial
Shanghai Henlius Biotech · Carcinoma, Hepatocellular
- HLX79Phase 21 trial
Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)
- HM15136Phase 21 trial
Hanmi Pharmaceutical Company Limited · Congenital Hyperinsulinism
- HM15421GC1134APhase 21 trial
GC Biopharma Corp · Fabry Disesase
- HMB-001Phase 21 trial
Hemab ApS · Glanzmann Thrombasthenia
- HMB-002Phase 21 trial
Hemab ApS · Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1, Von Willebrand Disease (VWD), Type 2
- HMBD-001Phase 21 trial
Hummingbird Bioscience · Advanced or Metastatic Squamous Non-Small Cell Lung Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Esophageal Squamous Cell Carcinoma
- HMPL-689Phase 21 trial
Hutchmed · Relapsed/Refractory Lymphoma
- HP-002Phase 21 trial
Shanghai Helioson Pharmaceutical Co., Ltd. · B-Cell Non-Hodgkin Lymphoma
- HP-211Phase 21 trial
Housey Healthcare ULC · Type 2 Diabetes
- HP515Phase 21 trial
Hinova Pharmaceuticals Inc. · NAFLD (Non-alcoholic Fatty Liver Disease)
- HP518Phase 21 trial
Hinova Pharmaceuticals Inc. · Metastatic Castration-resistant Prostate Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.